We are monitoring the current outbreak of Coronavirus Disease 2019 (COVID-19) very closely, while following updates and guidance from the World Health Organization.

Every precaution is being taken to ensure the health and safety of our entire DIA family.
Learn More
INSIDER ACCESS: DIA Member Exclusive

Who Owns My Health Data? Patients, Data & the Future of R&D: Watch the video, follow the interactive transcript, or download the audio to learn on the go.
Start Exploring
DIA Deep Dive: Genetic Therapies

Super-precise CRISPR tool enhanced by enzyme engineering could improve base editing and pave way for safer gene therapies.
Start Exploring
Patients at Heart of Middle East Drug Regulation: MERC 2019

Middle East health authorities proactively looking into adapting fast-track registration and other innovative regulatory reforms
Read Now
PODCAST: RIM Accelerating Efficiencies in Regulatory Pathways

As drug development and market approval grow more complex and connected, RIM can leverage regulatory data as a corporate asset
Listen Now
DIA NOW delivering Always-On Insights

Making the intersection of healthcare accessible anytime, anywhere, across any device. NEW Pharmacovigilance and Safety content!
Start Exploring
How Does DIA Membership Benefit You?
Connect with global influencers, and uncover ways to deliver impactful change
Access new knowledge that keeps you on the cutting-edge of healthcare conversations
Advance career development goals through best-in-class learning programs
Open doors to new pathways towards leadership growth
Expand your network to include global peers who support one another in real time
Christi Marsh
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Christi Marsh
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Global Forum, DIA's Digital Magazine
Uncover expert insights through global and regional coverage of the discovery, development, regulation, surveillance, and marketing of healthcare products, including interviews with thought leaders and topical summaries from educational events.
DIA's Podcast Channel
Get inside the minds of life science leaders as they share perspectives on current issues in healthcare product development, and the potential paths that lie ahead.